Novelion Therapeutics Added to the Russell 3000® & Russell Microcap® Indexes
26. Juni 2017 08:30 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, June 26, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals...
Novelion Therapeutics Announces Presentation of Metreleptin Data at American Diabetes Association
12. Juni 2017 08:30 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., June 12, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of...
Novelion Therapeutics Appoints John J. Orloff, M.D., to Its Board of Directors, Steps Down as EVP, Head of R&D
01. Juni 2017 16:01 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., June 01, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of...
Novelion Therapeutics Reports First Quarter 2017 Financial Results
09. Mai 2017 07:00 ET
|
Novelion Therapeutics, Inc.
Global Expansion Plans for Metreleptin Opportunity to be Announced this Summer Defined Clinical Development Plan for Zuretinol Following Positive FDA MeetingCompany Reiterates FY 2017 Total Net...
Novelion Therapeutics Announces Presentation of Metreleptin Data at American Association of Clinical Endocrinology
05. Mai 2017 09:00 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., May 05, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new...
Novelion Therapeutics to Announce First Quarter 2017 Financial Results on May 9, 2017
03. Mai 2017 16:15 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, May 03, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals...
Novelion Therapeutics Announces Presentation at the Bloom Burton & Co. Healthcare Investor Conference
25. April 2017 09:15 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, April 25, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics, Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new standards of care for...
Novelion Therapeutics’ Request to Voluntarily Delist from the Toronto Stock Exchange Granted
19. April 2017 16:15 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, April 19, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics, Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new standards of care for...
Metreleptin and Lipodystrophy Data Presented at the Annual Meeting of the Endocrine Society
04. April 2017 16:10 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia & CAMBRIDGE, Mass., April 04, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new...
Novelion Therapeutics Appoints Mark Corrigan, M.D. to Board of Directors
31. März 2017 08:00 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, March 31, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new standards of care for...